Anthelmintic activity of 3,6-dibenzyl-2,5-dioxopiperazine, cyclo(L-Phe-L-Phe)

Amino Acids

Volumn 12, Issue 1, 1997, Pages 41-47

  Walchshofer, N ^a   Sarciron, M E ^a   Garnier, F ^b   Delatour, P ^b   Petavy, A F ^a   Paris, J ^a  

^a UNIVERSITÉ LYON 1   (France)

^b VETAGRO SUP   (France)

Author keywords

2,5 piperazine dione; Amino acids; Anthelmintics; Cyclo(Phe Phe); Dipeptide; Hymenolepis nana; Schistosoma mansoni

Indexed keywords

3,6 DIBENZYL 2,5 DIOXOPIPERAZINE DERIVATIVE; ANTHELMINTIC AGENT; DIPEPTIDE; PRAZIQUANTEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHELMINTIC ACTIVITY; ARTICLE; BIOTRANSFORMATION; CESTODE; CONTROLLED STUDY; DRUG SPECIFICITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSFORMATION; ECHINOCOCCUS MULTILOCULARIS; GERBIL; HYMENOLEPIS NANA; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PH; PRIORITY JOURNAL;

ANIMALIA; CANIS FAMILIARIS; CESTODA; ECHINOCOCCUS MULTILOCULARIS; GERBILLINAE; HYMENOLEPIS NANA; MERIONES UNGUICULATUS; SCHISTOSOMA MANSONI; TREMATODA;

EID: 0031017977     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01373425     Document Type: Article

References (16)

1. Andrews P (1981) A summary of the efficacy of Praziquantel against schistosomes in animal experiments and notes on its mode of action. Arzneim Forsch 31: 538-541
2. Anonymous (1993) Treatment of schoolchildren for intestinal helminthiasis and schistosomiasis. Bull WHO 71: 466
3. Amman RJ, Tchudi K, Van Ziegler M, Meister F, Cotting J, Eckert J, Witassek F, Freiburghaus A (1988) The long-term course of 60 patients with alveolar echinococcosis in continuous therapy with mebendazole. Klin Wochenschr 66: 1060-1073
4. Bodor N, Sloan KB, Higuchi T, Sasahara K (1977) Improved delivery through biological membranes: 4. Prodrugs of L-Dopa. J Med Chem 20: 1435-1445
5. Delgado VS, Suarez DP, Cesari IM, Incari RN (1992) Experimental chemotherapy of Schistosoma mansoni with praziquantel and oxamniquine: differential effect of single or combined formulations of drugs on various strains and on both sexes of the parasite. Parasitology Res 78: 648-654
6. Gaines SM, Bada JL (1987) Reversed-phase high-performance liquid chromatographic separation of aspartame diastereoisomeric decomposition products. J Chromatogr 389: 219-225
7. Groll E (1984) Praziquantel. Adv Pharmacol Chemother 20: 219-237
8. Onica D, Rosendahl K, Waldenlind L (1990) Further characterization of a heat-stable alkaline phosphatase with low sensitivity to L-phenylalanine. Clin Chim Acta 194: 193-202
9. Pellegrino J, Faria J (1965) The oogram method for the screening of drugs in schistosomiasis mansoni. Am J Trop Med Hyg 14: 363-369
10. Rousset JJ (1989) Coproparasitologie pratique. Intérêt et methodologie. Notions sur les parasites du tube digestif. Estem, Paris, p 18
11. Sarciron ME, Hamoud W, Azzar G, Petavy AF (1991) Alkaline phosphatases from Echinococcus multilocularis: purification and characterization. Comp Biochem Physiol 100B: 253-258
12. Walchshofer N, Tinland B, Minjat M, Petavy AF, Paris J (1987) Recherche de paramètres structuraux influençant l'activité anthelminthique d'urées dérivées de thiadiazoles. Eur J Med Chem 22: 467-471
13. Walchshofer N, Sarciron ME, Arsac C, Walbaum S, Paris J, Petavy AF (1993) Biological effects of a dipeptide methylester on Echinococcus multilocularis metacestodes in vivo. Int J Pharm 100: 271-277
14. Walchshofer N, Sarciron ME, Paris J, Petavy AF, Delatour P (1994) Composés à activité anthelminthique: dicétopiperaxines, précurseurs et analogues. French patent no 94-09259, 21 July 94
15. WHO expert committee on the control of schistosomiasis (1993) Public health impact of schistosomiasis: disease and mortality. Bull WHO 71: 657-663
16. Witiak DT, Wei Y (1990) Dioxopiperazines: chemistry and biology. Prog Drug Res 35: 249-353